Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DPV-001 +/- INCAGN01876 with INCMGA00012 in Recurrent or Metastatic HNSCC
NCT04470024Phase 1Active, not recruiting
- Start
- Aug 2021
- Primary completion
- Dec 2027
- Modality
- Whole Cell Cancer Vaccines, Oncolytic Viruses, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
Phase 1, open-label trial of DPV-001 in head and neck squamous cell carcinoma (HNSCC) (2 arms). Primary endpoint: Adverse Events Assessment. Started Aug 2021; status: active, not recruiting.
02
Drugs
DPV-001
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT04470024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04470024.